US FDA turns down full approval of Amgen lung cancer drug Lumakras Ruchika Sharma29 Dec 2023 4:30 PM ISTNew Delhi: The U.S. health regulator on Tuesday declined to grant traditional approval to Amgen's Lumakras for treating lung cancer patients with...
Venus Remedies secures marketing nod from Israel, Colombia for two oncology drugs Ruchika Sharma29 Dec 2023 2:30 PM ISTChandigarh: Building on its international presence in the oncology space, Venus Remedies, has secured marketing authorisation for docetaxel from...
Janssen seeks EMA marketing nod for Lazertinib plus Rybrevant for EGFR-Mutated Non Small Cell Lung Cancer Ruchika Sharma25 Dec 2023 3:30 PM ISTBelgium: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a marketing authorisation application...
Lung Cancer Research: Delhi AIIMS invites chain smokers for low-dose CT Kajal Rajput24 Dec 2023 1:15 PM ISTNew Delhi: The All India Institute of Medical Sciences AIIMS, New Delhi will be conducting a study to see the effect of low-dose CT on early lung...
JnJ seeks USFDA nod for Rybrevant plus Lazertinib for EGFR-Mutated Non-Small Cell Lung Cancer Ruchika Sharma24 Dec 2023 12:30 PM ISTRaritan: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
Medical Bulletin 20/December/2023 Anshika Mishra20 Dec 2023 3:00 PM ISTHere are the top medical news of the day:Few patients receive opioid agonist therapy after opioid overdose, despite benefitsIn the week following any...
Lung nodule program provides benefits patients ineligible for lung cancer screening Anshika Mishra20 Dec 2023 9:15 AM ISTAdopting a lung nodule program (LNP) may increase the detection of early lung cancer for patients who are not eligible for lung cancer screening under...
Medical Bulletin 12/December/2023 Roshni Dhar12 Dec 2023 3:00 PM ISTHere are the top medical news of the day:Telehealth mindfulness recovery effective than usual care in individuals with opioid use disorder and painThe...
Bristol Myers Squibb, SystImmune collaborate for development, commercialization of BL-B01D1 Ruchika Sharma12 Dec 2023 12:30 PM ISTPrinceton: SystImmune, a clinical-stage biopharmaceutical company, and Bristol Myers Squibb have announced an exclusive license and collaboration...
Even little physical activity could be valuable in late-stage lung cancer Roshni Dhar12 Dec 2023 9:30 AM ISTNew research has found less than five minutes of daily physical activity could be linked with prolonged life in people living with inoperable forms of...
Type of Allergy medicine may have role in treatment of lung cancer Dr. Kamal Kant Kohli11 Dec 2023 9:45 AM ISTUSA: A recent study published in Nature has identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of...
Merck announces positive results from phase 2 trial evaluating coformulation of vibostolimab, pembrolizumab in lung cancer patients Ruchika Sharma10 Dec 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced full results from the non-registrational Phase 2 KeyVibe-002...
